ALLISON MCALLISTER: Open Payments
NPI 1902138456 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,414 in 69 payments from 27 companies in 2025. Trend: 2023 $2,066 · 2024 $2,143 · 2025 $2,414
Food & beverage: $2,394Education: $20
| Company | Payments | Amount |
|---|---|---|
| ASD Specialty Healthcare, LLC | 4 | $314 |
| Gilead Sciences, Inc. | 5 | $246 |
| Incyte Corporation | 3 | $208 |
| GENZYME CORPORATION | 2 | $202 |
| BeOne Medicines USA, Inc. | 4 | $192 |
| Ipsen Biopharmaceuticals, Inc | 2 | $138 |
| Novartis Pharmaceuticals Corporation | 8 | $135 |
| ABBVIE INC. | 5 | $128 |
| Daiichi Sankyo Inc. | 2 | $119 |
| Geron Corporation | 1 | $96 |
Products named: Trodelvy, BRUKINSA, SARCLISA, Onivyde, Zynyz, DATROWAY, RYTELO, MONJUVI.
Industry payments across AL — which companies pay providers there.
